Home Quality Indicators in Laboratory Medicine: from theory to practice
Article
Licensed
Unlicensed Requires Authentication

Quality Indicators in Laboratory Medicine: from theory to practice

Preliminary data from the IFCC Working Group Project “Laboratory Errors and Patient Safety”
  • Laura Sciacovelli EMAIL logo , Maurice O’Kane , Younis Abdelwahab Skaik , Patrizio Caciagli , Cristina Pellegrini , Giorgio Da Rin , Agnes Ivanov , Timothy Ghys , Mario Plebani and on behalf of the IFCC WG-LEPS
Published/Copyright: February 23, 2011

Abstract

Background: The adoption of Quality Indicators (QIs) has prompted the development of tools to measure and evaluate the quality and effectiveness of laboratory testing, first in the hospital setting and subsequently in ambulatory and other care settings. While Laboratory Medicine has an important role in the delivery of high-quality care, no consensus exists as yet on the use of QIs focussing on all steps of the laboratory total testing process (TTP), and further research in this area is required.

Methods: In order to reduce errors in laboratory testing, the IFCC Working Group on “Laboratory Errors and Patient Safety” (WG-LEPS) developed a series of Quality Indicators, specifically designed for clinical laboratories. In the first phase of the project, specific QIs for key processes of the TTP were identified, including all the pre-, intra- and post-analytic steps. The overall aim of the project is to create a common reporting system for clinical laboratories based on standardized data collection, and to define state-of-the-art and Quality Specifications (QSs) for each QI independent of: a) the size of organization and type of activities; b) the complexity of processes undertaken; and c) different degree of knowledge and ability of the staff. The aim of the present paper is to report the results collected from participating laboratories from February 2008 to December 2009 and to identify preliminary QSs.

Results and conclusions: The results demonstrate that a Model of Quality Indicators managed as an External Quality Assurance Program can serve as a tool to monitor and control the pre-, intra- and post-analytical activities. It might also allow clinical laboratories to identify risks that lead to errors resulting in patient harm: identification and design of practices that eliminate medical errors; the sharing of information and education of clinical and laboratory teams on practices that reduce or prevent errors; the monitoring and evaluation of improvement activities.


Corresponding author: Laura Sciacovelli, Dipartimento di Medicina di Laboratorio e Centro di Ricerca Biomedica, Azienda Ospedaliera Universita, Via Giustiniani 2, 35128 Padova, Italy Phone: +39 0498218708, Fax: +39 049663240

Received: 2010-9-27
Accepted: 2010-11-26
Published Online: 2011-02-23
Published in Print: 2011-05-01

©2011 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorials
  2. Laboratory testing and/or monitoring of the new oral anticoagulants/antithrombotics: for and against?
  3. Circulating macrocomplexes: old wine in new bottles?
  4. Review
  5. Laboratory assessment of new anticoagulants
  6. Minireviews
  7. Biomarkers in Alzheimer’s disease
  8. Analytical variability in sport hematology: its importance in an antidoping setting
  9. The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation
  10. Opinion Paper
  11. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality
  12. Genetics and Molecular Diagnostics
  13. Genetic variability of the fructosamine 3-kinase gene in diabetic patients
  14. Identification of Bcl-2/IgH fusion sequences using real-time PCR and chip-based microcapillary electrophoresis
  15. Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition
  16. Pharmacogenetics of tacrolimus after renal transplantation: analysis of polymorphisms in genes encoding 16 drug metabolizing enzymes
  17. General Clinical Chemistry and Laboratory Medicine
  18. Quality Indicators in Laboratory Medicine: from theory to practice
  19. Implementation of computerized add-on testing for hospitalized patients in a large academic medical center
  20. Human growth hormone (GH) immunoassay: standardization and clinical implications
  21. Coagulation assays based on the Luminescent Oxygen Channeling Immunoassay technology1)
  22. Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals
  23. Steroid binding properties of the 2nd WHO International Standard for sex hormone-binding globulin
  24. Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays
  25. Cancer Diagnostics
  26. Quantification of HER2 autoantibodies in the amplification phenomenon of HER2 in breast cancer
  27. Glycosylation of proteins in healthy and neoplastic human salivary glands – a preliminary study
  28. Infectious Diseases
  29. Quantification of cerebrospinal fluid lactic acid in the differential diagnosis between HIV chronic meningitis and opportunistic meningitis
  30. Cardiovascular Diseases
  31. Carotid restenosis is associated with plasma ADMA concentrations in carotid endarterectomy patients
  32. High concentrations of asymmetric dimethylarginine are associated with ST-segment resolution failure after reperfusion for acute myocardial infarction
  33. An increase in serum uric acid concentrations is associated with an increase in the Framingham risk score in Korean adults
  34. The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents
  35. False positive troponin result caused by a true macrotroponin
  36. Letters to the Editor
  37. Patient safety: patient identification wristband errors
  38. Prevalence of hemolytic specimens referred for arterial blood gas analysis
  39. “Triage” of lymphoid malignancies in the peripheral blood using the Extended Immunofluorescent Application of the CELL-DYN Sapphire automated hematology analyzer
  40. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.128/pdf?lang=en
Scroll to top button